Impact of ICU on the Quality of Life in Cancer Patients

University Hospital, Grenoble60 enrolled

Overview

This is an observational, prospective, monocentric, case-control study. Investigators aim to compare the quality of life and oncological treatment strategy in cancer patients admitted or not in ICU.

Inclusion of cancer patients (cases) at discharge of surgical, cardiovascular and thoracic and medical ICU of the Grenoble Alpes University Hospital. Cases will be matched with cancer patients identified in oncologist's consultation. Inclusion of controls from oncologist consultations (2 controls for 1 case) For cases and controls, medical data will be collected at inclusion, 3 and 6 months.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Solid Tumor, Adult

Interventions

QuestionnairesOTHER

Quality of life questionary: 36-Item Short Form Survey Instrument (36-SF) at 3 and 6 months from inclusion By phone

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * \> 18 ans * Non-opposition of the patient or relatives * Lung, head and neck or colorectal cancer * Non scheduled ICU admission * At least 24 hours of ICU stay * Alive at ICU discharge * Able to answer by phone to quality of life questionary Exclusion Criteria: * Unable to answer by phone to quality of life questionary * Patient participating in another clinical study that could interfere with the results of the study

Locations (1)

Chu Grenoble Alpes

Grenoble, France

Outcomes

Primary Outcomes

quality of life questionary 36-item short form survey instrument (36-SF)

score of 0 (poor quality of life) to 100 (very good quality of life)

Time frame: 3 months

Secondary Outcomes

intensity of antitumoral treatment compared to standard treatment

standard treatment vs adaptated treatment vs palliative care standard treatment was defined by the treatment recommended in the ESMO guidelines for each cancer (lung, colorectal, and head and neck cancer)

Time frame: 3 months

quality of life questionary 36-item short form survey instrument (36-SF)

score of 0 (poor quality of life) to 100 (very good quality of life)

Time frame: 6 months

intensity of antitumoral treatment compared to standard treatment

Time frame: 6 months

ECOG - Performance status

From 0 (fully active) to 5 (dead)

Time frame: 3 months and 6 months

Activities of Daily Living

From 0 (dependent ) to 6 (autonomous)

Time frame: 6 months

Hospital Anxiety and Depression Scale

Anxiety scale from 0 (no anxiety) to 21 (anxiety) Depression Scale from 0 (no depression) to 21 (depression)

Time frame: 3 months and 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.